AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06318351 — intervention group
Intervention type: PROCEDURE
Intervention: transcutaneous acupoint electrical stimulation
Description: This is a safe and non-invasive procedure, similar to an electrode sheet, which applies a weak current to a specific site to achieve the purpose of acupoint stimulation.
Study NCT06104982 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NeuroTrac MyoPlus Pro single-channel electromyography biofeedback electrotherapy devices
Description: Neuromuscular electrical stimulation (NMES) is applied to intact second motor neurons and target muscles of patients with SCI and provides functional and therapeutic benefits in neurological rehabilitation. Functional electrical stimulation (FES) is a type of NMES that is used for electrical stimulation during exercises such as crunches. Newly used SiFES is a method in which the biofeedback-enabled FES device detects muscle contractions, and this electromyography (EMG) signal triggers the muscle stimulant mode of the device.
Study NCT06104982 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Isometric strengthening exercises
Description: Isometric abdominal strengthening exercises are part of the standard rehabilitation program for individuals with spinal cord injuries.
Study NCT05838404 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: M-O-M-S on the Bayou
Description: Peer and mentor support and meetings across pregnancy
Study NCT05990751 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GD2 CAR T cells
Description: The GD2 CAR T cells target GD2 positive cells. The cells also express transgenes that aim to increase their resistance within the tumour microenvironment.
Study NCT05166915 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: UVA Light Emitting Catheter
Description: Experimental Device intended to eliminate microorganisms using UV-A light, thereby reducing the viral burden of SARS-CoV-2
Study NCT05166915 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Control Catheter
Description: Sham Control Device
Study NCT04778345 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 68Ga-FAPI PET/CT scan
Description: Each subject receives a single intravenous injection of 68Ga-FAPI, and undergo PET/CT imaging after 18F-FDG PET/CT scan during 2 days and 1 week.
Study NCT05761054 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: RT
Description: The treatment will be administered in 25 daily fractions (Monday-Friday) at the disease site to include the region of suspected micrometastatic spread (Clinical Target Volume 1, CTV1) at a dose of 50 Gy (2Gy~/ fraction) with SIB intensification on volume reduced corresponding to the interface sites between the tumor and the vascular / nerve axes (Clinical Target Volume 2, CTV2) at a dose of 60 Gy (2.4 Gy / fraction). The association with neoadjuvant chemotherapy based on anthracyclines is allowed.
Study NCT05525728 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Neurosensory
Description: Physiological and neurophysiological investigations
Study NCT06161662 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: transcutaneous electrical acupoint stimulation
Description: Electrodes will be attached on the surface of acupoints and electrical stimulation will be given
Study NCT06161662 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: Electrodes will be attached on the surface of acupoints but no stimulation will be given
Study NCT06508541 — intervention group
Intervention type: PROCEDURE
Intervention: ICG Guided surgery
Description: In ICG guided surgery group,Approximately 0.3 ml of ICG dissolved in 2.5 mg/ml of sterile water was injected submucosally by the endoscopic doctors through colonoscopy at two points around the tumor.All patients underwent standard complete mesocolic excision (CME) or total mesorectal excision (TME) with curable purpose using ICG lymphangiography procedure
Study NCT06508541 — intervention group
Intervention type: PROCEDURE
Intervention: conventional surgery
Description: All patients underwent standard complete mesocolic excision (CME) or total mesorectal excision (TME) with curable purpose
Study NCT06094504 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Spectral Lighting
Description: Spectral room lighting containing violet and blue wavelengths of light capable of stimulating non-visual opsins including OPN5 and OPN3.
Study NCT05790850 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pre-operative physical exercise
Description: Virtual instructor-guided twice weekly cycling-based high-intensity aerobic exercise program for a total of 30 days. Participants will use a study provided recumbent exercise bike and wristband fitness tracker to exercise and log the number of days they exercise with an instructor and self-directed cycling.
Study NCT05790850 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pre-operative mindfulness meditation practice
Description: Daily self-directed mindfulness practice involving a guided imagery meditation for a total of 30 days. Participants will use a study provided guided-imagery meditation audio file loaded to a study provided wristband fitness tracker. Participants will log the number of days they listen to the audio file or participate in self-directed solitary psychological support.
Study NCT05510921 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Minimalist music group
Description: Participants in this group will listen individually a live session of minimalist music piano piece, in a break room in the oncology sector, lasting between 10 and 15 minutes.
Study NCT05510921 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Minimalist music + birdsongs group
Description: Participants in this group will listen individually a live session of minimalist music piano piece with the superposition of bird song sounds, in a break room in the oncology sector, lasting between 10 and 15 minutes.
Study NCT05782270 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Warfarin
Description: dual antiplatelet therapy combined with warfarin
Study NCT05782270 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: DAPT
Description: Dual antiplatelet therapy (aspirin plus either clopidogrel or ticagrelor)
Study NCT05782270 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DAPT
Description: Dual antiplatelet therapy (aspirin plus either clopidogrel or ticagrelor)
Study NCT05782270 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: CE+CABG
Description: Coronary endarterectomy combined with coronary artery bypass grafting
Study NCT05782270 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CE+CABG
Description: Coronary endarterectomy combined with coronary artery bypass grafting
Study NCT05248451 — intervention group
Intervention type: OTHER
Intervention: Not an Interventional Study
Description: Not an Interventional Study
Study NCT04666571 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TOKA
Description: The device is a digitally planned (using individual CT scan measured anatomic data) personalised opening wedge high tibial osteotomy (HTO) procedure using a custom 3D printed surgical guide and plate.
Study NCT04666571 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Tomofix or ActivMotion
Description: The comparators, Tomofix and ActivMotion, are the most widely used devices for HTO procedures in the UK. Surgical procedures using the Tomofix and ActiveMotion are similar to TOKA, however, they are not patient specific and do not use custom-made plates.
Study NCT05140122 — intervention group
Intervention type: DRUG
Intervention: Multiple
Description: We will collect information on all medications taken by the caregiver and the person they care for.
Study NCT05140122 — intervention group
Intervention type: OTHER
Intervention: Multiple
Description: We will collect information on all forms of therapy or medical intervention taken by the caregiver and the person they care for.
Study NCT05876182 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Vancomycin
Description: The investigator will identify potential participants and confirm the diagnosis of PSC. Subjects will be screened within 10 weeks before randomization to determine the eligibility. Study participants will be consecutively randomized to oral vancomycin or placebo and investigational drug and placebo dispensed.
Study NCT05876182 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The investigator will identify potential participants and confirm the diagnosis of PSC. Subjects will be screened within 10 weeks before randomization to determine the eligibility. Study participants will be consecutively randomized to oral vancomycin or placebo and investigational drug and placebo dispensed.
Study NCT05248152 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Paracetamol and Ibuprofen
Description: Patients will receive paracetamol 1g and ibuprofen 400 mg before surgical incision.
Study NCT05248152 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pregabalin 150mg
Description: Patients will receive pregabalin 150 mg in the hour before surgery
Study NCT05248152 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients will receive a placebo capsule in the hour before surgery and two intravenous doses of saline before surgical incision.
Study NCT04497259 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Teleevaluation
Description: Patients will answer to a questionnaire filled through a chatbot link
Study NCT04497259 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Teleconsultation
Description: A teleconsultation (skype-like connection) at 6 and 9 months after surgery
Study NCT04872452 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Skin biopsy
Description: Any combination of the following six 3-6mm skin biopsies may be taken: palm, dorsum of hand, calf, other non-genital and non-face (this last one includes areas for use as negative controls which are not on the distal limbs). No more than 6 biopsies will be taken at one time.The biopsy size 3-6mm and method (punch, shave or wedge) will be done depending on the biologic assay destined for the biopsy. While 3mm will be sufficient for microarray analysis, 6mm will be required for any cell sorting preceding microarray analysis.
Study NCT04872452 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Skin biopsy
Description: Any combination of the following six 3-6mm skin biopsies may be taken: palm, dorsum of hand, calf, other non-genital and non-face (this last one includes areas for use as negative controls which are not on the distal limbs). No more than 6 biopsies will be taken at one time.The biopsy size 3-6mm and method (punch, shave or wedge) will be done depending on the biologic assay destined for the biopsy. While 3mm will be sufficient for microarray analysis, 6mm will be required for any cell sorting preceding microarray analysis.
Study NCT06135727 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Maestro2 OCT
Description: 3D Wide (12mmx9mm) OCT scan using the Maestro (Topcon, Japan)
Study NCT06495242 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Direct pulp capping and partial pulpotomy
Description: Two types of vital pulp therapy procedures
Study NCT05686590 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Augmented Reality Headset
Description: The simulation scenario will be a pediatric hypoglycemia-induced seizure case, which will be done through an AR simulation. AR (Augmented Reality) headset, which is a device that the participants will wear over their head and eyes and will add holographic elements to a live view of workplace training scenario.
Study NCT06225986 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LMH-4-DCP
Description: Reminiscence-based intervention for family caregiver-Persons with Dementia (PwD) dyads to record and reflect on meaningful memories to address family caregivers' pre-loss grief and enhance relationship quality.
Study NCT06225986 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: LMH-4-DCP access without reminiscence activities
Description: Participants in the attention control condition will have access to a version of LMH-4-DCP excluding reminiscence-specific activities.
Study NCT05827653 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NX210c
Description: 3 times a week, for 28 days
Study NCT05827653 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 3 times a week, for 28 days
Study NCT05655091 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FLU or CZO as continuous infusion
Description: Continuous infusion FLU or CZO coupled with real-time TDM and subsequent dose adjustment. A loading dose will be administered prior to the first continuous infusion. The loading dose (maximum of 2g as licensed according to the SmPC) and the dose of the continuous infusion will be calculated according to a pharmacokinetic model taking into account patient's characteristics (e.g. age, sex) and the measured drug concentration. The maximum daily dose of FLU and CZO will not exceed 12 grams per day according to the SmPC.
Study NCT05655091 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: standard FLU or CZO intermittent bolus administration
Description: Standard FLU or CZO intermittent bolus administration according to the local guidelines adjusted to the renal function without TDM-guided dose adjustment.
Study NCT05018767 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AlloRx
Description: cultured allogeneic adult umbilical cord derived mesenchymal stem cells
Study NCT05151848 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adalimumab Injection
Description: Adalimumab Injection injected subcutaneously every other week for 78 weeks
Study NCT05151848 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tofacitinib 5 MG
Description: Tofacitinib 5 MG BID taken orally for 78 weeks
Study NCT04323826 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: olive oil-water mixture
Description: 50% olive oil in water, processed with high shear mixer at 8000 rpm power without adding emulsifier, well shaked before consumption.
Study NCT04323826 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: olive oil-water emulsion
Description: 50% olive oil in water (4% whey protein isolate), stirred for 5 mins using a high shear mixer at 8000 rpm power and was further processed with high pressure homogenizer at 100 MPa.
Study NCT04323826 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: coconut oil-water mixture
Description: 50% coconut oil in water, processed with high shear mixer at 8000 rpm power without adding emulsifier, well shaked before consumption.
Study NCT04323826 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: coconut oil-water emulsion
Description: 50% coconut oil in water (4% whey protein isolate), stirred for 5 mins using a high shear mixer at 8000 rpm power and was further processed with high pressure homogenizer at 100 MPa.
Study NCT06159023 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: bronchial washing using a thin bronchoscope
Description: For intervention, we plan to perform bronchial washing using a thin bronchoscope instead of bronchoalveolar lavage with the conventional thick bronchoscope to diagnose pulmonary TB.
Study NCT05942430 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Autologous costal osteochondral transplantation
Description: Operating steps:~1. Arthroscopic examination of the size and location of the talar osteochondral lesion;~2. Make a transverse incision (approximately 4 cm long) at the osteochondral junction of the fifth or sixth rib, and harvest an osteochondral column from the rib;~3. Thoroughly remove the talar osteochonral lesion through arthrotomy or Chevron osteotomy of the medial malleolus;~4. Trim the autograft according to the size of the lesion;~5. Fill the peri-lesion cavity with cancellous bone, and finally embed the costal osteochondral autograft into the talar defect, ensuring that the cartilage surface of the transplant to be flush with the normal talar cartilage around it;~6. Suture the joint capsule or reduct and fix the medial malleolus, and close the incision layer by layer.
Study NCT05942430 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Autologous iliac osteoperiosteal transplantation
Description: Operating steps:~1. Arthroscopic examination of the size and location of the talar osteochondral lesion;~2. Make an incision along the anterior iliac crest. At the time of exposure, pay attention not to damage the periosteum. Obtain a cylindrical osteoperiosteal column by an appropriate-sized harvester tube.~3. Thoroughly remove the talar osteochonral lesion through arthrotomy or Chevron osteotomy of the medial malleolus;~4. Fill the peri-lesion cavity with cancellous bone, and finally embed the iliac osteoperiosteal autograft into the talar defect, ensuring that the periosteum surface of the transplant to be flush with the normal talar cartilage around it;~5. Suture the joint capsule or reduct and fix the medial malleolus, and close the incision layer by layer.
Study NCT06022783 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual reality intervention
Description: Watching a relaxing video with using VR-G for 20 minutes
Study NCT05067426 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: high-intensity interval training sessions
Study NCT05543278 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amiodarone
Description: Patients randomized to the Amiodarone Arm will receive a 5-day course of amiodarone after surgery.
Study NCT06033781 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Nightmares in Children
Description: The Cognitive Behavioral Therapy for Nightmares in Children (CBT-NC) is a brief, five-session manualized therapy designed to treat children ages 6-17. The manualized CBT protocol is five session that teach sleep hygiene, relaxation strategies, and addresses nightmares therapeutically through exposure and rescripting.
Study NCT06252259 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Choose to Move
Description: As described under study arm description
Study NCT05782322 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Upper-limb training involving RAS
Description: Three target bowls, labeled as the left, middle, and right target bowl, will be placed on the table at an equal distance from the main bowl. The distance between a target bowl and the main bowl is set at 30 cm. Wooden beads with a diameter of 2 cm will be put in target bowls. The main bowl will be placed in front of the patient.~Patients will be asked to listen to the RAS sound, use the right hand to take one bead at a time from the left target bowl to the main bowl, repeat this movement for the middle and right target bowls, and keep repeating this order. They should keep their movements consistent with the sound of the RAS, with one RAS sound corresponding to one pick-up movement.~Each daily training will consist of three rounds separated by two 5-minute breaks. Each round will consist of four consecutive sessions (for each session: 2-minute training followed by a 30-second break). The training will last for a total of 7 days.
Study NCT05782322 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Upper-limb training without the aid of RAS
Description: Three target bowls, labeled as the left, middle, and right target bowl, will be placed on the table at an equal distance from the main bowl. The distance between a target bowl and the main bowl is set at 30 cm. Wooden beads with a diameter of 2 cm will be put in target bowls. The main bowl will be placed in front of the patient.~Patients will be asked to use the right hand to take one bead at a time from the left target bowl to the main bowl, repeat this movement for the middle and right target bowls, and keep repeating this order. They are asked to execute the task as fast as possible.~Each daily training will consist of three rounds separated by two 5-minute breaks. Each round will consist of four consecutive sessions (for each session: 2-minute training followed by a 30-second break). The training will last for a total of 7 days.
Study NCT02078635 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Portfolio Plus Diet
Description: Foods on the Portfolio Plus plan will contribute 9 g/1000 kcal viscous fibre as β-glucan (oats, barley, oat bran bread and soups) and psyllium (cereal), 1 g plant sterol/1000 kcal diet (in sterol margarine), 22.5 g soy protein/1000 kcal (soy burgers, dogs, links, other soy meat analogues, soy milks, yogurts and cheese) and additional sources of plant proteins from pulses (eg. lentils, chickpeas, beans, etc); and 22.5 g almonds or equivalent of other nuts/1000 kcal and increase MUFA (as olive and canola oils, avocados, nuts, margarine and salad dressings). The glycemic index will be reduced from 83 to 70 GI units (bread scale)
Study NCT02078635 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: DASH-like (high fibre) dietary advice
Description: Dietary advice will be given to encourage intake of whole grain foods (brown rice, whole wheat breads, muffins and breakfast cereals); to reduce red meat consumption, choose low fat dairy foods and a control margarine
Study NCT04528862 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nature slides
Description: participants will view a presentation of nature slides
Study NCT04528862 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Urban slides
Description: participants will view a presentation of urban slides
Study NCT05967117 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Iohexol (320mgI/mL) with 120kVp
Description: Patient undergoing CT scan with 120kVp protocol and using Iobrix inj. 320 (Taejoon pharm, Seoul, South Korea). CT images were obtained 55sec after Contrast media injection(100mL, 2mL/sec) with 20mL saline flushing.